| Term 
 | Definition 
 
        | Asthma/COPD; Short-Acting β2-adrenergic receptor agonists (Also Oral) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Short-Acting β2-adrenergic receptor agonists |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Short-Acting β2-adrenergic receptor agonists (Also Oral) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Short-Acting β2-adrenergic receptor agonists (Also Oral) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Short-Acting β2-adrenergic receptor agonists |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Long-Acting β2-adrenergic receptor agonists |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Long-Acting β2-adrenergic receptor agonists |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Long-Acting β2-adrenergic receptor agonists |  | 
        |  | 
        
        | Term 
 
        | Beclomethasone Diproprionate |  | Definition 
 
        | Asthma/COPD; Inhaled Glucocorticoid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Inhaled Glucocorticoid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Inhaled Glucocorticoid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Inhaled Glucocorticoid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Inhaled Glucocorticoid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Inhaled Glucocorticoid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Leukotriene Receptor (Cys-LT1) Blocker; Competitive |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD and Allergic Rhinitis; Leukotriene Receptor (Cys-LT1) Blocker; Competitive |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Leukotriene Synthesis Inhibitor (Blocks 5-Lipoxygenase) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mild/Moderate Asthma; Allergic Rhinitis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Methylxantine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Methylxantine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Methylxantine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Methylxantine (theophylline preparation) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Methylxantine (theophylline preparation) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; PDE4 inhibitor (oral); increases cAMP levels reducing activities of immune cells; contraindicated in hepatic impairment |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; IV Muscarinic Receptor Antagonist (competitve) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Inhaled Muscarinic Receptor Antagonist (competitve) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Asthma/COPD; Anti-IgE monoclonal antibody that blocks portion of IgE that binds to mast and other inflammatory cells; also reduces receptor numbers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Not used in asthma; bronchodilator |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | rarely used in asthma; longer-acting broncodilator |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | rarely used in asthma; bronchodilator and expectorant |  | 
        |  | 
        
        | Term 
 
        | Oxymetazoline, Xylometazoline, Tetrahydrozoline, Naphazoline |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Phenylephrine, Pseudoephedrine |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Eicosanoid; PGE2 analog; cervical ripeining and abortion (vaginal suppository) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Eicosanoid; PGF2α analog; Abortion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Eicosanoid; PGE1 analog; Mucosal protective agent for NSAID induced gastric ulcers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Eicosanoid; PGE1 analog; Erectile dysfunction and to maintain ductus arteriosus in newborns until surgical closure |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Eicosanoid; IV PGI2 analog; Severe Pulmonary Arterial Hypertension (PAH) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Eicosanoid; Inhaled PGI2 analog; Severe Pulmonary Arterial Hypertension (PAH) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Eicosanoid; IV/SC/Inhaled PGI2 analog; Severe Pulmonary Arterial Hypertension (PAH) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PGF2α analog; Open-angle glaucoma eye drop |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | PGF2α analog; Open-angle glaucoma eye drop and enhances eyelash growth as a topical |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID (Oral and Suppository); antiplatelet |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID (Oral and Eye Drop) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID (Oral, IV, Suppository) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Fenoprofen, Flurbiprofen, Ibuprofen, Ketaprofen |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | NSAID (Oral, IV, Eye Drop) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-inflammatory; Acute and prophylactic gout treatment |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uricosuric; prophylactic gout therapy; also sometimes given with chosen beta-lactam antibiotics because it increases their plasma levels by competitively inhibiting their renal tubular secretion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Uricosuric; prophylactic gout therapy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Xanthanine Oxidase Inhibitor; prophylactic gout therapy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Xanthanine Oxidase Inhibitor; prophylactic gout therapy |  | 
        |  | 
        
        | Term 
 
        | Aluminum Hydroxide (also a combo drug with Magnesium Hydroxide) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Calcium Carbonate, Sodium Bicarbonate |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cimetidine, Ranitidine, Famotidine |  | Definition 
 
        | H2-Receptor Blocker; GERD and Peptic Ulcer Disease (Oral/IV) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | H2-Receptor Blocker; GERD and Peptic Ulcer Disease (Oral Only) |  | 
        |  | 
        
        | Term 
 
        | Omeprazole, Lansoprazole, Rabeprazole |  | Definition 
 
        | Proton Pump Inhibitor (PPI); Gerd and Peptic Ulcer Disease (Oral Only) |  | 
        |  | 
        
        | Term 
 
        | Pantoprazole, Esomeprazole |  | Definition 
 
        | Proton Pump Inhibitor (PPI); Gerd and Peptic Ulcer Disease (Oral/IV) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mucosal Protective Agent; Duodenal Ulcers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mucosal Protective Agent; Indigestion, ulcer caused by H.Pylori, and nonspecific diarrhea |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | D2 Receptor Antagonist; Gastric paresis, delayed gastric emptying |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Acetylcholinesterae (ACh) Inhibitor (IV); Acute colonic pseudo-obstruction in hospitalized patients |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bulk forming laxative (oral); safest most natural, usually for chronic constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bulk forming laxative (oral); safest most natural, usually for chronic constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bulk forming laxative (oral); safest most natural, usually for chronic constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bulk forming laxative (oral); safest most natural, usually for chronic constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Stool Surfactants (Softeners); oral and rectal; for patients who should avoid straining during defecation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lubricant Laxative; Oral and Rectal; temporary relief of occasional constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antacid and Saline Osmotic Laxative; acute constipation |  | 
        |  | 
        
        | Term 
 
        | Magnesium Citrate, Magnesium Sulfate |  | Definition 
 
        | Saline Osmotic Laxative; acute constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Saline Osmotic Laxative; acute constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-saline Osmotic Laxative; Rectal; acute constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-saline Osmotic Laxative; Oral and Rectal; acute constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Non-saline Osmotic Laxative; acute constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Stimulant Laxative; short-term treatment of constipation and for evacuation of the colon for bowel or rectal exams |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Stimulant Laxative; Oral and Rectal; short-term treatment of constipation and for evacuation of the colon for bowel or rectal exams |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Laxative; Chloride Channel Activator; chronic idiopathic constipation and constipation-predominant IBS in women |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Laxative; Opioid Receptor Antagonist (SubQ); Opioid-induced constipation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Laxative; Opioid Receptor Antagonist; Postoperative ileus to accelerate upper and lower GI recovery following partial large or small bowel resection surgery |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidiarrheal; Opioid agonist; Mild to moderate acute diarrhea and chronic diarrhea due to IBS of IBD; Does not cross BBB |  | 
        |  | 
        
        | Term 
 
        | Diphenoxylate (w/ atropine) |  | Definition 
 
        | Antidiarrheal; Opioid agonist; Mild to moderate acute diarrhea and chronic diarrhea due to IBS of IBD; Crosses BBB |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidiarrheal agent (SubQ/IV); GI neuroendocrine tumor-associated diarrhea |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antispasmodic; Anticholinergic antispasmodic; acute spasmodic attacks due to IBS |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Serotonin (5-HT3) receptor antagonist; severe diarrhea-predominant IBS in women non-responsive to conventional therapy |  | 
        |  | 
        
        | Term 
 
        | Mesalamine (5-ASA), Sulfasalazine, Balsalazide, Olsalazine |  | Definition 
 
        | Aminosalicylates; Mild to moderate ulcerative colitis (IBD) |  | 
        |  | 
        
        | Term 
 
        | Ondansetron, Granisetron, Dolasetron, Palonosetron |  | Definition 
 
        | Serotonin (5-HT3) receptor antagonists (Oral/IV); antiemetic agents for chemotherapy-induced nausea and vomiting and for postoperative/postradiation N/V |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Neurokinin 1 (NK1) receptor antagonist; Oral Antiemtic agents for prevention of N/V in patients receiving chemotherapy; given with 5-HT3 antagonists |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Neurokinin 1 (NK1) receptor antagonist; IV Antiemtic agents for prevention of N/V in patients receiving chemotherapy; given with 5-HT3 antagonists |  | 
        |  | 
        
        | Term 
 
        | Dexamethasone, Methylprednisolone |  | Definition 
 
        | Corticosteroids (Oral/IV); Antiemtic agents for prevention of N/V in patients receiving chemotherapy; given with 5-HT3 antagonists |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | D2 Receptor Antagonists (Oral/IV); Antiemtic agents for postoperative N/V |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | D2 Receptor Antagonists (IV/IM); Antiemtic agents for postoperative N/V |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | D2 Receptor Antagonists (Oral/IV); Antiemtic agents for postoperative N/V |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | D2 Receptor Antagonists (Oral/IV); Antiemtic agents for postoperative N/V |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Generation Antihistamine; H1 Receptor Antagonist; Antiemetic agent for prevention and treatment of N/V, vertigo associated with motion sickness; Symptomatic relief of allergic rhinitis and urticaria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Generation Antihistamine; H1 Receptor Antagonist (Oral/IV); Antiemetic agent for prevention and treatment of N/V, vertigo associated with motion sickness; Symptomatic relief of allergic rhinitis and urticaria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic Receptor Antagonist (Oral/Transdermal Patch); Antiemetic agent for prevention and treatment of N/V, vertigo associated with motion sickness |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cannabinoids; Antiemetic agents for chemotherapy induced N/V |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Pancreatic Enzyme Supplement; pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatic resection |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Bile Acid Therapy; gallstones in patients with symptomatic gallbladder disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria; OTC cough suppressant |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |  | 
        |  | 
        
        | Term 
 
        | Brompheniramine, Chlorpheniramine |  | Definition 
 
        | 1st Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2nd Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | "3rd" Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | "3rd" Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | "3rd" Generation Antihistamine; Symptomatic relief of allergic rhinitis and urticaria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Selective Serotonin Receptor Agonists (Oral/Nasal/SubQ); Severe migraines, cluster headaches  **not for prophylaxis b/c of ADRs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Selective Serotonin Receptor Agonists (Oral/Nasal); Severe migraines, cluster headaches  **not for prophylaxis b/c of ADRs |  | 
        |  | 
        
        | Term 
 
        | Almotriptan, Eletriptan, Frovatriptan, Rizatriptan, Naratriptan |  | Definition 
 
        | Selective Serotonin Receptor Agonists (ORAL); Severe migraines, cluster headaches  **not for prophylaxis b/c of ADRs |  | 
        |  | 
        
        | Term 
 
        | Triple Antibiotic Ointment |  | Definition 
 
        | Bacitracin, Neomycin, Polymixin B; topical antibacterial agent |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topical antibacterial agent; works against gram +/- bacteria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topical antibacterial agent; works against gram +/- bacteria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topical antibacterial agent; works against MRSA, gram + bacteria, and some anaerobic gram - bacteria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topical antibacterial agent; works against gram - bacteria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topical antibacterial agent; works against gram - bacteria; usually in combination ointments and the most frequent cause of skin reactions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topical antibacterial agent; works against gram - bacteria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topical antibacterial agent; acne vulgaris |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topical antibacterial agent; acne vulgaris |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topical antibacterial agent; acne vulgaris |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topical antibacterial agent; acne vulgaris |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topical antibacterial agent; works against gram + cocci; safe for pediatric use |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topical antifungal agent; often combined with a corticosteroid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topical antifungal agent; also available as a shampoo for seborrheic dermatitis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Agent used to treat malathion poisoning |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ectoparasiticide; Organophosphate cholinesterase inhibitor; head and pubic lice |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ectoparasiticides; last resort agent for head and pubic lice |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Given to replenish the body's GSH stores and prevent hepatotoxicity in the event of an APAP overdose |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Absorbs APAP in the GI in the event of an overdose |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Laxative for preparation of bowel for examination or surgery |  | 
        |  |